Vitamin D analogue plus corticosteroid combination

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

0 marketed 3 in Phase 3

This page covers all Vitamin D analogue plus corticosteroid combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Vitamin D receptor (VDR) and glucocorticoid receptor (GR), Vitamin D receptor (VDR); glucocorticoid receptor.

Targets

Vitamin D receptor (VDR) and glucocorticoid receptor (GR) · Vitamin D receptor (VDR); glucocorticoid receptor

Phase 3 pipeline (3)

Calcipotriol plus betamethasone · LEO Pharma · Dermatology
Calcipotriol (a vitamin D analogue) and betamethasone (a corticosteroid) work together to reduce skin inflammation and normalize keratinocyte differentiation in psoriasis.
Calcipotriol plus hydrocortisone ointment vehicle · LEO Pharma · Dermatology
Calcipotriol (a vitamin D analogue) reduces keratinocyte proliferation and promotes differentiation, while hydrocortisone provides anti-inflammatory effects to treat psoriasis.
Calcipotriol plus hydrocortisone ointment · LEO Pharma · Dermatology
Calcipotriol (a vitamin D analogue) reduces skin cell proliferation and promotes differentiation, while hydrocortisone (a corticosteroid) suppresses inflammation and immune responses in the skin.

Patent intelligence

vitamin d analogue plus corticosteroid combination patent landscape — aggregated cliff calendar, attackable patents, originator estates